NTRR Expands Opportunities in California's $1.3 Billion Medical Marijuana Market
SARASOTA, Fla.--(BUSINESS WIRE)-- Neutra Corp. (OTCBB: NTRR), a growth-oriented provider of all-natural wellness solutions, opened talks this week with a second mergers and acquisitions target in California's booming $1.3 billion medical marijuana (MMJ) market.
NTRR is finalizing a new joint venture with an emerging MMJ company developing a suite of cannabinoid delivery-system products, including smokeless vaporizers. Now, NTRR expects to sign a letter of intent in the coming days to partner with a second company specializing in oral delivery systems for cannabinoids, as well.
"California is on the cutting edge of MMJ innovations, and we're working very aggressively to develop the business relationships we need to become a dominant player in this emerging market," Mr. Jim said. "Thorough research has convinced us of a strong and rising demand for alternative MMJ delivery systems such as capsules, throat sprays, transdermal patches and more. We're very excited about the possibility of partnering with an emerging leader in this sector who can assist us in bringing these high-value products to the patients who need them."
Smoke-free cannabinoid delivery systems have exploded in popularity with MMJ users in recent years because they deliver the same therapeutic effects of the drug without the potential dangers and restrictions associated with smoking. NTRR is pursuing an ambitious mergers and acquisitions strategy to help introduce the next wave of new MMJ innovations and technologies to the explosive $1.7 billion market that is continuing to grow across the country.
NTRR has made California the staging point for its efforts to build market share in the industry by basing its new medicinal cannabis subsidiary—Cannabis Technologies, Inc.—in Los Angeles. Since voters approved California's medical marijuana program in 1996, the state has become home to the largest MMJ market in the U.S., with an estimated 750,000 qualified patients.
By providing innovative nutraceutical products and services such as new MMJ breakthroughs, Neutra Corp. plans to follow in the footsteps of other successful public companies including Cannabis Science, Inc. (PINK: CBIS), Medical Marijuana Inc. (PINK: MJNA) and Terra Tech Corp. (PINK: TRTC), delivering technological advancements in the cultivation and processing of cannabis in approved markets.
For more information on NTRR's initiatives, please visit www.neutracorp.com/investors.html.
About Neutra Corp.
Neutra Corp. (www.neutracorp.com) is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. For investing information and performance data, please visit www.neutracorp.com/investors.html.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Sydney Jim, 713-821-1486
President and CEO
KEYWORDS: United States North America California Florida
The article NTRR Expands Opportunities in California's $1.3 Billion Medical Marijuana Market originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.